Since Chinese shares tend to trade outside the mainland at lower valuations, there is an element of arbitrage in the gains.
Investors are trying to parse the demographics, arbitrage windows, bottlenecks and distortions of an Asian nappy market with annual sales of about $12bn, forecast by CLSA to reach $45bn by 2030.
But there is another, grubbier motive: regulatory arbitrage.
